GSK to spend $800M to build two vaccine factories in the US

Anna Brown

News Reporter

GSK said it is making its largest manufacturing investment in the US yet, allocating $800 million to upgrade its vaccine production site in Pennsylvania. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

GSK to spend $800M to build two vaccine factories in the US

Anna Brown

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson

Sanofi backs fibrosis biotech Agomab as it raises $89M Series D

Septerna bags $288M upsized IPO for GPCR drugs

Sanofi reports sales jump for Beyfortus as RSV antibody challenger from Merck nears

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

GSK to spend $800M to build two vac­cine fac­to­ries in the US

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

GSK to spend $800M to build two vaccine factories in the US